Atlas Trials

A Phase I Clinical Study of Hemay808

Clinical trial NCT04100642 · COMPLETED

Trial details

NCT number
NCT04100642
Sponsor
Tianjin Hemay Pharmaceutical Co., Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Safety Issues
Start date
2019-04-08
Primary completion
2019-10-23
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.